Opinion
Video
Author(s):
Medical professionals discuss their ideal patients for surgery, and who would be best suited for pharmacologic intervention.
Sotagliflozin Cuts MACE Risk By 23% in Patients with Type 2 Diabetes, CKD
Diabetes Dialogue: Omnipod 5 and Medtronic 780G for Type 2 Diabetes
CELZ-201 Cuts Insulin Dependency at 1 Year in Patients with Type 2 Diabetes
Medical Ethics Unpacked: GLP-1 Allocation and Challenges of Equitable Access
Investigating the Link Between Type 2 Diabetes and Infection
Endocrinology Month in Review: January 2025